139 related articles for article (PubMed ID: 36939643)
1. A Comparison of Daily Glucose Fluctuation Between GCK-MODY and Type 2 Diabetes Using Continuous Glucose Monitoring Technology.
Ren Q; Zhang P; Pang W; Ma Y; Gong S; Ba T; Liu W; Zhang F; Zhang X; Zhang R; Wang X; Zhang X; Yang W; Lv F; Gao L; Han X; Ji L
Diabetes; 2023 Jun; 72(6):812-818. PubMed ID: 36939643
[TBL] [Abstract][Full Text] [Related]
2. Glucokinase-maturity onset diabetes mellitus in the young suggested by factory-calibrated glucose monitoring data: a case report.
Nomura N; Iizuka K; Goshima E; Hosomichi K; Tajima A; Kubota S; Liu Y; Takao K; Kato T; Mizuno M; Hirota T; Suwa T; Horikawa Y; Yabe D
Endocr J; 2022 Apr; 69(4):473-477. PubMed ID: 34803122
[TBL] [Abstract][Full Text] [Related]
3. Two novel GCK mutations in Chinese patients with maturity-onset diabetes of the young.
Wang T; Zhu M; Wang Y; Hu C; Fang C; Hu J
Endocrine; 2024 Jan; 83(1):92-98. PubMed ID: 37847371
[TBL] [Abstract][Full Text] [Related]
4. Insights from basic adjunctive examinations of GCK-MODY, HNF1A-MODY, and type 2 diabetes: A systemic review and meta-analysis.
Liu J; Xiao X; Zhang Q; Yu M
J Diabetes; 2023 Jun; 15(6):519-531. PubMed ID: 37226652
[TBL] [Abstract][Full Text] [Related]
5. Recognition and Management of Individuals With Hyperglycemia Because of a Heterozygous Glucokinase Mutation.
Chakera AJ; Steele AM; Gloyn AL; Shepherd MH; Shields B; Ellard S; Hattersley AT
Diabetes Care; 2015 Jul; 38(7):1383-92. PubMed ID: 26106223
[TBL] [Abstract][Full Text] [Related]
6. Caudal regression syndrome in a fetus of a glucokinase-maturity-onset diabetes of the young pregnancy.
Taylor RAM; Mackie A; Mogra R; Pinner J; Rajendran S; Ross GP
Diabet Med; 2019 Feb; 36(2):252-255. PubMed ID: 30362177
[TBL] [Abstract][Full Text] [Related]
7. Genetic deletion of a short fragment of glucokinase in rabbit by CRISPR/Cas9 leading to hyperglycemia and other typical features seen in MODY-2.
Song Y; Sui T; Zhang Y; Wang Y; Chen M; Deng J; Chai Z; Lai L; Li Z
Cell Mol Life Sci; 2020 Aug; 77(16):3265-3277. PubMed ID: 31720743
[TBL] [Abstract][Full Text] [Related]
8. The clinical management of hyperglycemia in pregnancy complicated by maturity-onset diabetes of the young.
Bacon S; Schmid J; McCarthy A; Edwards J; Fleming A; Kinsley B; Firth R; Byrne B; Gavin C; Byrne MM
Am J Obstet Gynecol; 2015 Aug; 213(2):236.e1-7. PubMed ID: 25935773
[TBL] [Abstract][Full Text] [Related]
9. The 0.1% of the population with glucokinase monogenic diabetes can be recognized by clinical characteristics in pregnancy: the Atlantic Diabetes in Pregnancy cohort.
Chakera AJ; Spyer G; Vincent N; Ellard S; Hattersley AT; Dunne FP
Diabetes Care; 2014; 37(5):1230-6. PubMed ID: 24550216
[TBL] [Abstract][Full Text] [Related]
10. Genetic and clinical characteristics of Chinese children with Glucokinase-maturity-onset diabetes of the young (GCK-MODY).
Li X; Ting TH; Sheng H; Liang CL; Shao Y; Jiang M; Xu A; Lin Y; Liu L
BMC Pediatr; 2018 Mar; 18(1):101. PubMed ID: 29510678
[TBL] [Abstract][Full Text] [Related]
11. Glucokinase gene mutations (MODY 2) in Asian Indians.
Kanthimathi S; Jahnavi S; Balamurugan K; Ranjani H; Sonya J; Goswami S; Chowdhury S; Mohan V; Radha V
Diabetes Technol Ther; 2014 Mar; 16(3):180-5. PubMed ID: 24405491
[TBL] [Abstract][Full Text] [Related]
12. GCK gene mutations are a common cause of childhood-onset MODY (maturity-onset diabetes of the young) in Turkey.
Haliloglu B; Hysenaj G; Atay Z; Guran T; Abalı S; Turan S; Bereket A; Ellard S
Clin Endocrinol (Oxf); 2016 Sep; 85(3):393-9. PubMed ID: 27256595
[TBL] [Abstract][Full Text] [Related]
13. A single dose of dapagliflozin, an SGLT-2 inhibitor, induces higher glycosuria in GCK- and HNF1A-MODY than in type 2 diabetes mellitus.
Hohendorff J; Szopa M; Skupien J; Kapusta M; Zapala B; Platek T; Mrozinska S; Parpan T; Glodzik W; Ludwig-Galezowska A; Kiec-Wilk B; Klupa T; Malecki MT
Endocrine; 2017 Aug; 57(2):272-279. PubMed ID: 28593615
[TBL] [Abstract][Full Text] [Related]
14. Pregnancy in Women With Monogenic Diabetes due to Pathogenic Variants of the Glucokinase Gene: Lessons and Challenges.
Timsit J; Ciangura C; Dubois-Laforgue D; Saint-Martin C; Bellanne-Chantelot C
Front Endocrinol (Lausanne); 2021; 12():802423. PubMed ID: 35069449
[TBL] [Abstract][Full Text] [Related]
15. Glucokinase mutations in pediatric patients with impaired fasting glucose.
Aloi C; Salina A; Minuto N; Tallone R; Lugani F; Mascagni A; Mazza O; Cassanello M; Maghnie M; d'Annunzio G
Acta Diabetol; 2017 Oct; 54(10):913-923. PubMed ID: 28726111
[TBL] [Abstract][Full Text] [Related]
16. Iatrogenic Hyperinsulinemia, Not Hyperglycemia, Drives Insulin Resistance in Type 1 Diabetes as Revealed by Comparison With GCK-MODY (MODY2).
Gregory JM; Smith TJ; Slaughter JC; Mason HR; Hughey CC; Smith MS; Kandasamy B; Greeley SAW; Philipson LH; Naylor RN; Letourneau LR; Abumrad NN; Cherrington AD; Moore DJ
Diabetes; 2019 Aug; 68(8):1565-1576. PubMed ID: 31092478
[TBL] [Abstract][Full Text] [Related]
17. Clinical heterogeneity in monogenic diabetes caused by mutations in the glucokinase gene (GCK-MODY).
Cuesta-Muñoz AL; Tuomi T; Cobo-Vuilleumier N; Koskela H; Odili S; Stride A; Buettger C; Otonkoski T; Froguel P; Grimsby J; Garcia-Gimeno M; Matschinsky FM
Diabetes Care; 2010 Feb; 33(2):290-2. PubMed ID: 19903754
[TBL] [Abstract][Full Text] [Related]
18. Clinical implications of the glucokinase impaired function - GCK MODY today.
Hulín J; Škopková M; Valkovičová T; Mikulajová S; Rosoľanková M; Papcun P; Gašperíková D; Staník J
Physiol Res; 2020 Dec; 69(6):995-1011. PubMed ID: 33129248
[TBL] [Abstract][Full Text] [Related]
19. Phenotype Heterogeneity in Glucokinase-Maturity-Onset Diabetes of the Young (GCK-MODY) Patients.
Wędrychowicz A; Tobór E; Wilk M; Ziółkowska-Ledwith E; Rams A; Wzorek K; Sabal B; Stelmach M; Starzyk JB
J Clin Res Pediatr Endocrinol; 2017 Sep; 9(3):246-252. PubMed ID: 28663157
[TBL] [Abstract][Full Text] [Related]
20. Mild fasting hyperglycemia in children: high rate of glucokinase mutations and some risk of developing type 1 diabetes mellitus.
Codner E; Rocha A; Deng L; Martínez-Aguayo A; Godoy C; Mericq V; Chung WK
Pediatr Diabetes; 2009 Sep; 10(6):382-8. PubMed ID: 19309449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
